Article Text

PDF
Treating rheumatic diseases in pregnancy: dos and don’ts
  1. M D Lockshin
  1. Correspondence to:
    M D Lockshin
    Barbara Volcker Center for Women and Rheumatic Disease, Mary Kirkland Center for Lupus Research, Joan and Sanford Weill College of Medicine of Cornell University, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021; LockshinM{at}hss.edu

Abstract

This paper presents a critical appraisal of the current evidence and recommendations regarding the use of pharmaceuticals and biologicals in pregnancy. Clinical experience is often at variance with published recommendations as studies have not taken into account the differences in physiology in the various stages of gestation and between animal and human pregnancies. Physicians should bear in mind that pregnancy causes disruption in several organ systems; the effects of an intervention may depend on the stage of gestation; and some effects of interventions in pregnancy may not manifest until adulthood.

  • rheumatic diseases
  • rheumatoid arthritis
  • treatment
  • pregnancy
  • precautions

Statistics from Altmetric.com

Footnotes

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.